Table 4.
Relationship between ApoB/ApoA1 ratio and clinicopathological characteristics in the 1,201 GC patients
| Characteristics | ApoB/ApoA1 ratio <1 | ApoB/ApoA1 ratio ≥1 | P-value |
|---|---|---|---|
| Age (years) | 0.058 | ||
| <60 | 551 | 406 | |
| ≥60 | 124 | 120 | |
| Sex | 0.005 | ||
| Male | 644 | 187 | |
| Female | 313 | 57 | |
| Tumor location | 0.091 | ||
| Lower third | 479 | 104 | |
| Upper third | 439 | 131 | |
| Full third | 39 | 9 | |
| Tumor size (cm) | 0.321 | ||
| <5 | 532 | 127 | |
| ≥5 | 425 | 117 | |
| Differentiation | 0.044 | ||
| Well/moderate | 152 | 52 | |
| Poor/others | 805 | 192 | |
| TNM stage | 0.166 | ||
| I | 151 | 33 | |
| II | 204 | 48 | |
| III | 526 | 133 | |
| IV | 76 | 30 | |
| Blood type | 0.041 | ||
| A | 250 | 85 | |
| B | 237 | 47 | |
| O | 402 | 95 | |
| AB | 68 | 17 |
Note: The bold value denotes statistical significance (P<0.05).
Abbreviations: ApoA1, Apolipoprotein A1; ApoB, Apolipoprotein B; GC, gastric cancer; TNM, tumor–node–metastasis.